- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01909518
Detection of Early Esophageal Squamous Neoplasia
July 24, 2013 updated by: Yanqing Li, Shandong University
Detection of Early Esophageal Squamous Neoplasia by Using Virtual Chromoendoscopy and Probe-based Confocal Laser Endomicroscopy
The aim of the present study:
- To investigate the diagnosing value of pCLE for early esophageal squamous neoplasia.
- To assess the detection rate of early esophageal squamous neoplasia by virtual chromoendoscopy
Study Overview
Status
Unknown
Detailed Description
Probe-based confocal laser endomicroscopy (pCLE; Cellvizio, Mauna Kea Technologies, Paris, France) is a newly developed endoscopic device and has shown its value for diagnosing Barrett's esophagus, colonal polyps and etc.
However, none research has focus on early esophageal squamous neoplasia until now.
Previous diagnosis of early esophageal neoplasia is based on the lugol staining which is time wasting and have many adverse events.Other researches have suggested virtual chromoendoscopys are beneficial for screening esophageal tumors.
Therefore, the aim of the present study is 1.To investigate the diagnosing value of pCLE for early esophageal squamous neoplasia according to the surface maturation scoring(SMS) diagnostic criteria and 2. To assess the detection rate of early esophageal squamous neoplasia by virtual chromoendoscopy(I-SCAN).
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yangqing li, PhD. MD
- Phone Number: 82169508 86-531-82169236
- Email: liyanqing@sdu.edu.cn
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Department of Gastroenterology, Qilu Hospital, Shandong University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Consecutive patients screened that fulfill the eligibility criteria at Qilu Hospital, Shandong University will be enrolled into the study
Description
Inclusion Criteria:
- Patients aged between 50 and 80 years old
- Patients undergo screening endoscopy or histologically verified esophageal squamous intraepithelial neoplasia before.
Exclusion Criteria:
- Advanced esophageal, gastric or duodenal cancer
- History of upper GI tract surgery
- Coagulopathy or acute GI bleeding
- Pregnant or breast-feeding (for females)
- Impaired renal function
- Allergy to fluorescein sodium
- Inability to provide informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
pCLE examination
pCLE is used to distinguish the suspected lesions detected by I-SCAN in esophagus
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The diagnostic accuracy of pCLE on early esophageal squamous neoplasia
Time Frame: 6 month
|
Patients will be prospectively recruited to evaluate the diagnostic sensitivity, specificity and accuracy of early esophageal squamous neoplasia by using probe-based confocal laser endomicroscopy
|
6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yanqing Li, MD. PhD., Qilu Hospital, Shandong University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2013
Primary Completion (ANTICIPATED)
December 1, 2013
Study Completion (ANTICIPATED)
December 1, 2013
Study Registration Dates
First Submitted
July 24, 2013
First Submitted That Met QC Criteria
July 24, 2013
First Posted (ESTIMATE)
July 26, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
July 26, 2013
Last Update Submitted That Met QC Criteria
July 24, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013SDU-QILU-G02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Squamous Intraepithelial Neoplasia
-
National Cancer Institute (NCI)Active, not recruitingCervical Intraepithelial Neoplasia Grade 2/3 | High Grade Cervical Intraepithelial Neoplasia | Cervical Squamous Cell Carcinoma In Situ | Cervical Squamous Intraepithelial Neoplasia 2United States
-
Medtronic - MITGCompletedAnal Intraepithelial Neoplasia (AIN) | High-grade Squamous Intraepithelial Lesions (HSIL)United States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCRecruitingCervical Intraepithelial Neoplasia | Cervical Squamous Cell Carcinoma In Situ | Cervical Squamous Intraepithelial Neoplasia 2United States
-
Institut de Cancérologie de LorraineRecruitingVulvar Intraepithelial Neoplasia | Vulvar High Grade Squamous Intraepithelial Lesion | Differentiated Vulvar Intraepithelial NeoplasiaFrance
-
Shandong UniversityUnknownEarly Esophageal Squamous NeoplasiaChina
-
Catharina Ziekenhuis EindhovenZonMw: The Netherlands Organisation for Health Research and Development; Stichting... and other collaboratorsRecruitingCervical Intraepithelial Neoplasia | CIN 2/3 | Cervical Intraepithelial Neoplasia Grade 2/3 | Cervical High Grade Squamous Intraepithelial LesionNetherlands
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedHigh Grade Anal Canal Intraepithelial Neoplasia | High Grade Vulvar Squamous Intraepithelial LesionUnited States
-
Medtronic - MITGTerminatedEsophageal Squamous Cell Neoplasia (ESCN)China
-
University of WashingtonNational Cancer Institute (NCI)CompletedCervical Carcinoma | Human Papillomavirus Infection | Health Status Unknown | Cervical Intraepithelial Neoplasia Grade 2/3 | Stage 0 Cervical Cancer | Atypical Squamous Cell of Undetermined Significance | Low Grade Cervical Squamous Intraepithelial NeoplasiaUnited States
-
Medtronic - MITGCompletedHIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-Grade Squamous Intraepithelial LesionsUnited States